RAM Investment Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$211K Sell
229
-5
-2% -$5.07K 0.04% 118
2025
Q4
$251K Sell
234
-213
-48% -$204K 0.05% 89
2025
Q3
$341K Buy
447
+21
+5% +$15.6K 0.06% 77
2025
Q2
$332K Buy
426
+10
+2% +$7.77K 0.07% 71
2025
Q1
$343K Buy
416
+25
+6% +$20.8K 0.08% 65
2024
Q4
$302K Sell
391
-58
-13% -$48K 0.07% 71
2024
Q3
$397K Buy
449
+18
+4% +$16.2K 0.1% 54
2024
Q2
$390K Sell
431
-96
-18% -$76.8K 0.11% 53
2024
Q1
$410K Buy
+527
New +$375K 0.13% 50

Other funds holding LLY

RAM Investment Partners's LLY Position: Q1 2026 in Review

RAM Investment Partners reduced its Eli Lilly (LLY) stake by 2.1% in Q1 2026, selling an estimated $5.07K and leaving 229 shares worth $211K. The position accounts for 0.04% of the portfolio, ranked #118.

RAM Investment Partners first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $410K in Q1 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • RAM Investment Partners held 229 shares of Eli Lilly worth $211K as of Q1 2026.
  • RAM Investment Partners sold 5 Eli Lilly shares in Q1 2026, an estimated $5.07K.
  • Eli Lilly made up 0.04% of RAM Investment Partners's portfolio in Q1 2026, its #118 holding.
  • RAM Investment Partners first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
  • RAM Investment Partners's Eli Lilly position peaked at $410K in Q1 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on RAM Investment Partners's 13F filing for Q1 2026, filed 4 May 2026.